117 related articles for article (PubMed ID: 29885161)
1. Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up.
Życzkowski M; Prokopowicz G; Taborowski P; Nowakowski K; Rajwa P; Stelmach P; Paradysz A
Med Sci Monit; 2018 Jun; 24():3895-3902. PubMed ID: 29885161
[TBL] [Abstract][Full Text] [Related]
2. Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma.
Prokopowicz G; Życzkowski M; Nowakowski K; Bogacki R; Bryniarski P; Paradysz A
Biomed Res Int; 2016; 2016():8687575. PubMed ID: 28105437
[No Abstract] [Full Text] [Related]
3. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
[TBL] [Abstract][Full Text] [Related]
4. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative platelet count in patients with gallbladder cancer.
Wang RT; Zhang LQ; Mu YP; Li JB; Xu XS; Pang Q; Sun LK; Zhang X; Dong SB; Wang L; Liu C
World J Gastroenterol; 2015 May; 21(17):5303-10. PubMed ID: 25954104
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
[TBL] [Abstract][Full Text] [Related]
7. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival.
Vasudev NS; Brown JE; Brown SR; Rafiq R; Morgan R; Patel PM; O'Donnell D; Harnden P; Rogers M; Cocks K; Anderson K; Paul A; Eardley I; Selby PJ; Banks RE
Clin Cancer Res; 2008 Mar; 14(6):1775-81. PubMed ID: 18347179
[TBL] [Abstract][Full Text] [Related]
11. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
[TBL] [Abstract][Full Text] [Related]
12. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma.
Rasmuson T; Grankvist K; Ljungberg B
Acta Oncol; 1996; 35(4):479-82. PubMed ID: 8695165
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
Gakis G; Fritsche HM; Hassan F; Kluth L; Miller F; Soave A; Otto W; Schwentner C; Todenhöfer T; Dahlem R; Burger M; Fisch M; Stenzl A; Aziz A; Rink M
Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
Chang X; Zhang F; Liu T; Wang W; Guo H
Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
[TBL] [Abstract][Full Text] [Related]
17. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
18. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
19. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma.
Ohno Y; Nakashima J; Ohori M; Hatano T; Tachibana M
J Urol; 2010 Sep; 184(3):873-8. PubMed ID: 20643463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
